Benign atypical intravascular CD30+ T-cell proliferation: A reactive condition mimicking intravascular lymphoma

American Journal of Dermatopathology

Volumn 35, Issue 2, 2013, Pages 143-150

  Riveiro Falkenbach, Erica ^a   Fernández Figueras, María Teresa ^b   Rodríguez Peralto, José Luis ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Atypical intravascular CD30+; Intravascular lymphoma; Pseudolymphoma CD30+; Reactive process

Indexed keywords

CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; KI 67 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; EPIDERMIS HYPERPLASIA; FEMALE; HUMAN; INFLAMMATORY INFILTRATE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; NEUTROPHIL CHEMOTAXIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PYOGENIC GRANULOMA; SKIN BIOPSY; SKIN DEFECT; SKIN NODULE; SYSTEMIC DISEASE; T CELL LYMPHOMA;

ADOLESCENT; ANTIGENS, CD30; BLOOD VESSELS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; SKIN DISEASES;

EID: 84878916573     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182323119     Document Type: Article

References (14)

1. Roglin J, Boer A. Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin. Br J Dermatol. 2007;157:16.
2. Gleason BC, Brinster NK, Granter SR, et al. Intravascular cytotoxic T-cell lymphoma: a case report and reviewof the literature. J Am Acad Dermatol. 2008;58:290-294.
3. Ko YH, Han JH, Go JH, et al. Intravascular lymphomatosis: a clinicopathological study of two cases presenting as an interstitial lung disease. Histopathology. 1997;31:555.
4. Takahashi E, Kajimoto K, Fukatsu T, et al. Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression. Virchows Arch. 2005;447:1000.
5. Falini B, Pileri S, Pizzolo G, et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood. 1995;85:1-14.
6. de Leval L, Gaulard P. CD30+ lymphoproliferative disorders. Haematologica. 2010;95:1627-1630.
7. Kash N, Ginter-Hanselmayer G, Cerroni L. Cutaneous mycotic infections with pseudolymphomatous infiltrates. Am J Dermatopathol. 2010;32:514-517.
8. Massi D, Trotta M, Franchi A, et al. Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection. Am J Dermatopathol. 2004;26:234-236.
9. Werner B, Massone C, Kerl H, et al. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin. J Cutan Pathol. 2008;35: 1100-1107.
10. Calzado-Villarreal L, Polo-Rodríguez I, Ortiz-Romero PL. Primary cutaneous CD30+ lymphoproliferative disorders. Actas Dermosifiliogr. 2010;101:119-128.
11. Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. 2006; 33(suppl. 1):58-70.
12. Willemze R, Jaffe E, Burge G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
13. Baum CL, Stone MS, Liu V. Atypical intravascular CD30+ T-cell proliferation following trauma in a healthy 17-year-old male: first reported case of a potential diagnostic pitfall and literature review. J Cutan Pathol. 2009;36:350-354.
14. Ardighieri L, Lonardi S, Vermi W, et al. Intralymphatic atypical T-cell proliferation in a cutaneous hemangioma. J Cutan Pathol. 2010;37:497-503.